BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28099581)

  • 21. Immunoglobulin gene rearrangement in detection of minimal residual disease in acute lymphoblastic leukaemia.
    Nayyar A; Ahmed S
    J Ayub Med Coll Abbottabad; 2013; 25(1-2):159-61. PubMed ID: 25098084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Real-time quantitative study of minimal residual disease in childhood B cell acute lymphoblastic leukemia].
    Jia YP; Liu GL; Zhang LP
    Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):600-4. PubMed ID: 15347448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia.
    Verhagen OJ; Willemse MJ; Breunis WB; Wijkhuijs AJ; Jacobs DC; Joosten SA; van Wering ER; van Dongen JJ; van der Schoot CE
    Leukemia; 2000 Aug; 14(8):1426-35. PubMed ID: 10942239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
    van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
    Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
    Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
    Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of monoclonal gene rearrangement for detection of minimal residual disease in acute lymphoblastic leukemia of childhood.
    Sykes PJ; Snell LE; Brisco MJ; Neoh SH; Hughes E; Dolman G; Peng LM; Bennett A; Toogood I; Morley AA
    Leukemia; 1997 Jan; 11(1):153-8. PubMed ID: 9001432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia.
    Jo I; Chung NG; Lee S; Kwon A; Kim J; Choi H; Jang W; Kim S; Lee JW; Yoon JH; Cho B; Han K; Kim Y; Kim M
    Clin Chim Acta; 2019 Jan; 488():81-89. PubMed ID: 30389459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Polish pediatric acute lymphoblastic leukemia patients--implications for RQ-PCR-based assessment of minimal residual disease.
    Dawidowska M; Derwich K; Szczepański T; Jółkowska J; van der Velden VH; Wachowiak J; Witt M
    Leuk Res; 2006 Sep; 30(9):1119-25. PubMed ID: 16476479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.
    Shin S; Hwang IS; Kim J; Lee KA; Lee ST; Choi JR
    Ann Lab Med; 2017 Jul; 37(4):331-335. PubMed ID: 28445014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL.
    Chen H; Gu M; Liang J; Song H; Zhang J; Xu W; Zhao F; Shen D; Shen H; Liao C; Tang Y; Xu X
    Nat Commun; 2023 Nov; 14(1):7468. PubMed ID: 37978187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia.
    Nunes V; Cazzaniga G; Biondi A
    Expert Rev Mol Diagn; 2017 Nov; 17(11):953-963. PubMed ID: 28891364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of T cell receptor beta gene rearrangements and its role in minimal residual disease detection in childhood T-cell acute lymphoblastic leukemia].
    Liu JY; Li ZG; Gao C; Cui L; Wu MY
    Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):487-92. PubMed ID: 19099802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy.
    Assumpção JG; Ganazza MA; de Araújo M; Silva AS; Scrideli CA; Brandalise SR; Yunes JA
    Pediatr Blood Cancer; 2010 Dec; 55(7):1278-86. PubMed ID: 20730889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
    Marshall GM; Kwan E; Haber M; Brisco MJ; Sykes PJ; Morley AA; Toogood I; Waters K; Tauro G; Ekert H
    Leukemia; 1995 Nov; 9(11):1847-50. PubMed ID: 7475273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic changes: relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia.
    Cole-Sinclair MF; Foroni L; Hoffbrand AV
    Baillieres Clin Haematol; 1994 Jun; 7(2):183-233. PubMed ID: 7803899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.
    Flohr T; Schrauder A; Cazzaniga G; Panzer-Grümayer R; van der Velden V; Fischer S; Stanulla M; Basso G; Niggli FK; Schäfer BW; Sutton R; Koehler R; Zimmermann M; Valsecchi MG; Gadner H; Masera G; Schrappe M; van Dongen JJ; Biondi A; Bartram CR;
    Leukemia; 2008 Apr; 22(4):771-82. PubMed ID: 18239620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gene rearrangement pattern of immunoglobulin and T-cell receptor (Ig/TR) and its clinical characteristics in children with SET-NUP214 fusion gene-positive leukemia/lymphoma].
    Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xin YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1362-7. PubMed ID: 22169284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.
    Brüggemann M; van der Velden VH; Raff T; Droese J; Ritgen M; Pott C; Wijkhuijs AJ; Gökbuget N; Hoelzer D; van Wering ER; van Dongen JJ; Kneba M
    Leukemia; 2004 Apr; 18(4):709-19. PubMed ID: 14961040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
    Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.